Anebulo begins phase 1 trial of IV cannabis toxicity treatment
PositiveFinancial Markets

Anebulo has initiated a phase 1 trial for its innovative intravenous cannabis toxicity treatment, marking a significant step in addressing cannabis-related health issues. This trial is crucial as it explores a new therapeutic avenue that could potentially improve patient outcomes and safety in cannabis use, reflecting the growing interest in medical cannabis solutions.
— Curated by the World Pulse Now AI Editorial System